NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cellestial Health

Cellestial Health

Private
CambridgeHealthcare & Life Scienceshttps://cellestialhealth.com/

Last Round

Seed

Dec 2, 2025

Total Funding Raised

$1.18M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cellestial Health is a biopharmaceutical company developing small molecule therapeutics designed to slow the progression of neurodegenerative diseases by targeting astrocytes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysmall-molecule therapeuticsneurodegenerative diseasedrug discoveryastrocytic networksParkinson's diseasecentral nervous systemCNSpreclinical drug developmentbrain-permeable drugsbiotech startupdisease-modifying treatmentdrug pipelinebiopharmatherapeutic research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellestial Health Comps

Public and private peers based on sector, stage, and business model.

Cellestial Health comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellestial Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 2, 2025
GrantSep 19, 2025
Pre SeedMay 8, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Nat Hastings

Chief Executive Officer

Executive Team

Cellestial Health Investors

Notable investors and investment history

Cellestial Health investors
InvestorRounds
ZincPre Seed
Parkinson's UKGrant
Alma AngelsPre Seed
Cambridge EnterpriseGrant
SFC CapitalPre Seed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors increased 72% MoM.

  • May 8, 2025

    $654K raised in Pre Seed round.

View all signals

Cellestial Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellestial Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellestial Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range4
Year Founded2023
Last FundingDec 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.